Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119939844 | 11993984 | 4 | F | 20150831 | 20160916 | 20160203 | 20160927 | EXP | PHHY2016US009227 | SANDOZ | 62.00 | YR | M | Y | 114.00000 | KG | 20160927 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119939844 | 11993984 | 1 | SS | DIOVAN | VALSARTAN | 1 | Oral | 160 MG, QD | 0 | 160 | MG | QD | |||||||
| 119939844 | 11993984 | 2 | PS | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | 76859 | 5 | MG | QD | |||||||
| 119939844 | 11993984 | 3 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, UNK | 0 | 25 | MG | TABLET | |||||||
| 119939844 | 11993984 | 4 | SS | BUMETANIDE. | BUMETANIDE | 1 | Oral | 1 MG, QD | 0 | 1 | MG | QD | |||||||
| 119939844 | 11993984 | 5 | SS | CARVEDILOL. | CARVEDILOL | 1 | Oral | 6.25 MG, BID | 0 | 6.25 | MG | BID | |||||||
| 119939844 | 11993984 | 6 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | QD | |||||||
| 119939844 | 11993984 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 0 | 75 | MG | QD | |||||||
| 119939844 | 11993984 | 8 | C | RANOLAZINE | RANOLAZINE | 1 | Oral | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
| 119939844 | 11993984 | 9 | C | RANOLAZINE | RANOLAZINE | 1 | Oral | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
| 119939844 | 11993984 | 10 | C | ASA | ASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | QD | |||||||
| 119939844 | 11993984 | 11 | C | ASA | ASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | QD | |||||||
| 119939844 | 11993984 | 12 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TID | |||||||
| 119939844 | 11993984 | 13 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TID | |||||||
| 119939844 | 11993984 | 14 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Oral | 150 MG, QD | 0 | 150 | MG | QD | |||||||
| 119939844 | 11993984 | 15 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG, BID | 0 | 40 | MG | BID | |||||||
| 119939844 | 11993984 | 16 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 119939844 | 11993984 | 17 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 600 MG, TID | 0 | 600 | MG | TID | |||||||
| 119939844 | 11993984 | 18 | C | NOVOLOG | INSULIN ASPART | 1 | Oral | 18 IU, TID | 0 | 18 | IU | TID | |||||||
| 119939844 | 11993984 | 19 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 62 IU, AT BEDTIME | 0 | 62 | IU | ||||||||
| 119939844 | 11993984 | 20 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 119939844 | 11993984 | 21 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 119939844 | 11993984 | 22 | C | IMDUR | ISOSORBIDE MONONITRATE | 1 | Oral | 120 MG, QD | 0 | 120 | MG | QD | |||||||
| 119939844 | 11993984 | 23 | C | IMDUR | ISOSORBIDE MONONITRATE | 1 | Oral | 120 MG, QD | 0 | 120 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119939844 | 11993984 | 1 | Hypertension |
| 119939844 | 11993984 | 2 | Hypertension |
| 119939844 | 11993984 | 3 | Hypertension |
| 119939844 | 11993984 | 4 | Hypertension |
| 119939844 | 11993984 | 5 | Hypertension |
| 119939844 | 11993984 | 6 | Atrial fibrillation |
| 119939844 | 11993984 | 8 | Angina pectoris |
| 119939844 | 11993984 | 10 | Antiplatelet therapy |
| 119939844 | 11993984 | 12 | Back pain |
| 119939844 | 11993984 | 14 | Depression |
| 119939844 | 11993984 | 15 | Depression |
| 119939844 | 11993984 | 16 | Hyperlipidaemia |
| 119939844 | 11993984 | 17 | Product used for unknown indication |
| 119939844 | 11993984 | 18 | Type 2 diabetes mellitus |
| 119939844 | 11993984 | 19 | Type 2 diabetes mellitus |
| 119939844 | 11993984 | 20 | Gastrooesophageal reflux disease |
| 119939844 | 11993984 | 21 | Hyperlipidaemia |
| 119939844 | 11993984 | 22 | Angina pectoris |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119939844 | 11993984 | LT |
| 119939844 | 11993984 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119939844 | 11993984 | Acute kidney injury | |
| 119939844 | 11993984 | Hypotension | |
| 119939844 | 11993984 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119939844 | 11993984 | 1 | 2002 | 0 | ||
| 119939844 | 11993984 | 2 | 2002 | 0 | ||
| 119939844 | 11993984 | 3 | 2002 | 0 | ||
| 119939844 | 11993984 | 4 | 2014 | 0 | ||
| 119939844 | 11993984 | 5 | 2002 | 0 | ||
| 119939844 | 11993984 | 6 | 2013 | 0 | ||
| 119939844 | 11993984 | 7 | 20150831 | 0 | ||
| 119939844 | 11993984 | 8 | 2012 | 0 | ||
| 119939844 | 11993984 | 9 | 20150831 | 0 | ||
| 119939844 | 11993984 | 10 | 1991 | 0 | ||
| 119939844 | 11993984 | 11 | 20150831 | 0 | ||
| 119939844 | 11993984 | 12 | 2007 | 0 | ||
| 119939844 | 11993984 | 13 | 20150831 | 0 | ||
| 119939844 | 11993984 | 14 | 2002 | 0 | ||
| 119939844 | 11993984 | 15 | 2002 | 0 | ||
| 119939844 | 11993984 | 16 | 2014 | 0 | ||
| 119939844 | 11993984 | 17 | 1992 | 0 | ||
| 119939844 | 11993984 | 18 | 2005 | 0 | ||
| 119939844 | 11993984 | 19 | 2005 | 0 | ||
| 119939844 | 11993984 | 20 | 2002 | 0 | ||
| 119939844 | 11993984 | 21 | 2005 | 0 | ||
| 119939844 | 11993984 | 22 | 2010 | 0 | ||
| 119939844 | 11993984 | 23 | 20150831 | 0 |